Related Experiment Video
Updated: Jun 8, 2026
11:31
Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
Published on: July 4, 2018
Mast cell death induced by 24(S),25-epoxycholesterol
Makiko Fukunaga1, Satoshi Nunomura, Shigeru Nishida
1Division of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University Graduate School of Medical Science, 30-1 Oyaguchikami-cho Itabashi-ku, Tokyo 173-8610, Japan.
Experimental Cell Research
|September 22, 2010
Summary
This study shows that 24(S),25-epoxycholesterol triggers programmed cell death (apoptosis) in mast cells. This process involves increased neutral lipid accumulation, offering new therapeutic targets for inflammatory diseases.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Mast cells are key players in inflammatory responses.
- Inhibiting mast cell growth is a therapeutic strategy for immune diseases like rheumatoid arthritis and allergies.
- Lipid metabolism critically influences cell survival and lifespan.
Purpose of the Study:
- To investigate the effect of oxysterols on mast cell apoptosis.
- To elucidate the role of lipid metabolism in oxysterol-induced mast cell death.
Main Methods:
- Utilized bone marrow-derived murine mast cells.
- Administered 24(S),25-epoxycholesterol, an endogenous oxysterol.
- Analyzed neutral lipid accumulation and its link to apoptosis.
Main Results:
- 24(S),25-epoxycholesterol induced apoptosis in mast cells.
- Acyl-CoA:cholesterol acyltransferase-catalyzed neutral lipid accumulation was identified as a key factor in this apoptosis.
- This highlights a novel mechanism of oxysterol action on mast cells.
Conclusions:
- Oxysterols, specifically 24(S),25-epoxycholesterol, can induce mast cell apoptosis.
- Neutral lipid metabolism, regulated by acyl-CoA:cholesterol acyltransferase, plays a significant role in oxysterol-mediated mast cell apoptosis.
- These findings provide new insights into targeting lipid metabolism for managing inflammatory conditions involving mast cells.